Effect of Low Valine Diet on Body Weight and Metabolic Parameters
Recruiting now · Not applicable
Conditions studied: Overweight/obesity, Metabolic Associated Fatty Liver Disease, Metabolic Diseases
In brief
This study aimed to explore the effects of ordinary meal replacements and low-valine meal replacements on the weight and risk of related metabolic diseases in overweight/obese patients through a randomized double-blind controlled clinical trial.
Key facts
- Study ID
- NCT06883578
- Run by
- Shanghai Zhongshan Hospital
- People needed
- 48
- Starts
- 2025-02-18
- Expected to finish
- 2026-04-30
- Last updated by the study team
- 2025-03-19
Who can join
Age: 16 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or female, 16 years old ≤ age ≤ 80 years old;
- BMI ≥ 24kg/m2
You may not qualify if…
- Excessive drinkers (defined as: in the past 6 months, the weekly alcohol intake of men exceeds 140g, and that of women exceeds 70g);
- Liver diseases caused by other reasons: such as alcoholic liver disease, acute and chronic viral hepatitis, drug-induced, immune hepatitis (AMA, SMA, ANA), cirrhosis, liver cancer, etc.;
- Other diseases that affect glucose and lipid metabolism: hyperthyroidism, hypothyroidism, Cushing's syndrome, etc.;
- Poorly controlled diabetic patients: HbA1c >9.5% within three months; or use of hypoglycemic drugs that may affect weight, including pioglitazone, GLP-1, SGLT2 inhibitors;
- Chronic kidney disease or severe renal impairment, defined as serum creatinine greater than 2.0mg/dL;
- Serum ALT greater than 3 times the upper limit of normal;
- Life expectancy of no more than 3 years in the presence of serious health conditions;
- Those who plan to get pregnant in the near future;
- Those who cannot participate in the follow-up of the intervention due to other conditions;
- Continuously used drugs that may cause weight changes for more than 2 weeks in the past year (such as glucocorticoids, thyroid hormones, etc.);
- Participated in other clinical trials in the past 4 weeks;
- Those who had gastric volume reduction surgery or digestive tract surgery;
- Those diagnosed with any tumor disease;
- Subjects who participated in strenuous exercise or planned to change their diet structure;
- Unable to sign the informed consent form.
Where it is running
- Zhongshan Hospital, Fudan University — Shanghai, Shanghai Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.